[Antibodies against Herpes simplex virus type 2 among pregnant women in Norway].
The prevalence of antibodies against herpes simplex virus type 2 (anti-HSV-2) among pregnant women in Norway is not known. To study the prevalence of anti-HSV-2, a random sample of 961 women was drawn from a study population of 35,940 pregnant women in Norway during 1992-94. 27% (256/961) had anti-HSV-2. The prevalence increased with age. 17% of the 20-24-year-olds and 34% of the 35 year-old or older had anti-HSV-2. The presence of antibodies also varied geographically, from 18% in the south to 39% in the north of Norway. Among women with repeated anti-HSV-2 tests during pregnancy, 2.6% of the seronegative women seroconverted (16/623). HSV-2 infection is common among pregnant women in Norway. The public health implications of this infection need to be clarified.
Eskild
A
A
Avdeling for samfunnsmedisin Statens institutt for folkehelse, Oslo.
Jeansson
S
S
Jenum
P A
PA
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D005260:Female; D006558:Herpes Genitalis / Q000453:epidemiology* / Q000276:immunology; D018258:Herpesvirus 2, Human / Q000276:immunology*; D006801:Humans; D008423:Maternal Age; D009664:Norway / Q000453:epidemiology; D010298:Parity; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D015995:Prevalence; D011446:Prospective Studies
D000914:Antibodies, Viral
Herpes simplex-virus type 2-antistoffer hos gravide i Norge.